Free Trial

First Manhattan CO. LLC. Sells 6,938 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • First Manhattan CO. LLC reduced its stake in Procter & Gamble by 2.7%, owning 245,867 shares valued at approximately $41.9 million.
  • Procter & Gamble reported $1.48 EPS for the last quarter, exceeding estimates, and a revenue of $20.89 billion, up 1.7% year-over-year.
  • The company declared a quarterly dividend of $1.0568, resulting in an annualized yield of 2.7% and a payout ratio of 64.98%.
  • Interested in Procter & Gamble? Here are five stocks we like better.

First Manhattan CO. LLC. cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 245,867 shares of the company's stock after selling 6,938 shares during the quarter. First Manhattan CO. LLC.'s holdings in Procter & Gamble were worth $41,901,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cladis Investment Advisory LLC lifted its stake in Procter & Gamble by 5.2% in the fourth quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock worth $806,000 after acquiring an additional 236 shares during the period. Benjamin Edwards Inc. lifted its stake in shares of Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after purchasing an additional 199,258 shares during the period. Capital Investment Advisory Services LLC grew its holdings in Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock valued at $6,426,000 after purchasing an additional 4,562 shares during the period. World Investment Advisors boosted its stake in shares of Procter & Gamble by 6.0% in the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after acquiring an additional 2,886 shares during the period. Finally, Concurrent Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock valued at $20,451,000 after purchasing an additional 25,059 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Marc S. Pritchard sold 9,849 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider owned 182,422 shares in the company, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 120,181 shares of company stock worth $18,918,012. Company insiders own 0.18% of the company's stock.

Procter & Gamble Price Performance

Shares of PG traded up $0.03 on Wednesday, reaching $158.02. The stock had a trading volume of 6,509,285 shares, compared to its average volume of 6,154,013. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $370.13 billion, a PE ratio of 24.27, a PEG ratio of 4.14 and a beta of 0.36. The firm has a 50-day moving average of $156.40 and a 200 day moving average of $162.34. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is presently 64.98%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Wells Fargo & Company cut their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Barclays set a $164.00 price target on shares of Procter & Gamble and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Evercore ISI reiterated an "in-line" rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. BNP Paribas reiterated an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $175.12.

View Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines